1 1

FDA BLA 125057, Supplement S-400, Humira, Approved on October 17, 2016

FDA BLA 125057, Supplement S-400, Humira, Approved on October 17, 2016

$184.95 USD
$184.95 USD
Sale Sold out

Content: Approval letter and supporting records for Humira, BLA 125057, Supplement S-400, approved on October 17, 2016, partially redacted.

Drug Name: Humira
Active Ingredients: Adalimumab
Strength: 40MG/0.8ML
Dosage Form/Route: Both Syringe and Vial
Marketing Status: Prescription
TE Code: None
RLD: No
RS: NoAction Date: 12/31/2002

Pages: 137
Redacted Pages: 102
Content Pages: 35
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome